These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 559690)

  • 21. Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.
    Cuellar FG
    Obstet Gynecol; 1980 Mar; 55(3):278-84. PubMed ID: 6987580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ineffectiveness of pyridoxine in evaluation and treatment of the hyperprolactinemic amenorrhea-galactorrhea syndrome.
    Goodenow TJ; Malarkey WB
    Am J Obstet Gynecol; 1979 Jan; 133(2):161-4. PubMed ID: 570356
    [No Abstract]   [Full Text] [Related]  

  • 23. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P; Giannola C; Palisi F
    Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of the long-term use of parlodel in different forms of lactorrhea].
    Mel'nichenko GA; Pishulin AA; Gitel' EG; Nazarenko VA
    Sov Med; 1984; (1):59-64. PubMed ID: 6701657
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovulatory response to clomiphene citrate during bromocriptine-failed ovulation in amenorrhea-galactorrhea and hyperprolactinemia.
    Turksoy RN; Biller BJ; Farber M; Cetrulo C; Mitchell GW
    Fertil Steril; 1982 Mar; 37(3):441-4. PubMed ID: 6800855
    [No Abstract]   [Full Text] [Related]  

  • 30. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 31. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 32. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.
    Friesen HG; Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():91S-99S. PubMed ID: 617073
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of the amenorrhea-galatorrhea-anovulation syndrome with bromocryptin and the results].
    Markovski N; Ivanov S
    Akush Ginekol (Sofiia); 1980; 19(1):46-52. PubMed ID: 7377513
    [No Abstract]   [Full Text] [Related]  

  • 40. The natural history of idiopathic hyperprolactinemia.
    Martin TL; Kim M; Malarkey WB
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.